Nanoparticle Coated Microelectrode Arrays for Electrochemically Controlled Gene Editing at the Electrode Site

用于电极位点电化学控制基因编辑的纳米颗粒涂层微电极阵列

• 批准号: 10604904
• 负责人: NATHANIEL P WILLIAMS
• 金额: $ 7.86万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-06-01 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10604904
• 关键词: Affect; Afferent Neurons; Antiinflammatory Effect; Area; Astrocytes; Biocompatible Coated Materials; Brain; Cell Culture Techniques; Cells; Cellular Morphology; Chronic; Cicatrix; Clinical; Clustered Regularly Interspaced Short Palindromic Repeats; DNA; DNA Sequence; Development; Devices; Electrodes; Encapsulated; Equipment Malfunction; Failure; Fluorescence; Foreign Bodies; Formulation; Gene Delivery; Gene Expression; Gene Modified; Gene Transduction Agent; Gene Transfer; Genes; Gliosis; Hearing; Immune response; Implant; In Vitro; Inflammation; Inflammatory; Inflammatory Response; Intervention; Knock-out; Life; Limb structure; Longevity; Measures; Medicine; Metals; Microelectrodes; Microglia; Modification; Monitor; Mus; Neurons; Pathway interactions; Patients; Pattern; Perception; Performance; Play; Porosity; Property; Prosthesis; Proteins; Reporter; Reporter Genes; Resolution; Role; Sensory; Silicon Dioxide; Site; Specificity; Structure; Surface; System; Technology; Testing; Therapeutic; Therapeutic Uses; Time; Tissues; Touch sensation; Vision; Work; bioelectronics; brain computer interface; cell type; experimental study; gene therapy; implantable device; implantation; improved; in vitro testing; in vivo; knockout gene; limb loss; loss of function; mechanical device; nanoparticle; neural; neuron loss; neurotransmission; novel; prevent; prosthesis control; recruit; response; robot control; spatiotemporal; technology development; tool; two photon microscopy; vector

Abstract Microelectrode arrays (MEAs) have great potential for therapeutic use in direct brain-computer interface (BCI) control of robotic prostheses to improve the lives of patients suffering from debilitating conditions related to loss of limbs or limb function. MEAs also have the potential to restore loss of sensory perception in vision, hearing, and tactile sensation by applying patterned current stimulation to sensory neurons. As promising as these therapies are, there is a major shortcoming to the current state of the art in implanted MEAs in that their recording and stimulation quality degrades over time, and the implants eventually become non-functional. Their use as therapeutic devices to treat chronic conditions that persist for the patient's life requires MEAs that are stable over decades rather than months to years. The underlying mechanisms leading to failure for chronically implanted MEAs have yet to be fully elucidated. One candidate is degradation of the electrode or insulation material leading to mechanical device failure. Another important factor is the host foreign body response. Inflammation due to activation of microglia and astrocytes can lead to gliosis and the formation of a “glial scar” encapsulating the device and preventing efficient recording and stimulation of neurons. Recently, gene therapy-based interventions using CRISPR/Cas systems for gene knockout have shown great promise in modifying the immune response. Recent work in the Cui lab has shown the efficacy of using functionalized silica nanoparticles (SNPs) as a versatile surface modification for microelectrodes. MEAs coated with polyethylenedioxythiophene (PEDOT)/SNP have improved electrochemical properties over standard bare metal electrodes and the capacity to be loaded with therapeutic compounds due to their porous structure with a high surface area. These properties make MEAs coated with PEDOT/SNP an ideal platform for highly targeted gene delivery, as the silica nanoparticles can be efficiently loaded with DNA. This proposal aims to develop this technology to efficiently gene modify microglia locally around implanted MEAs to reduce inflammation and to measure the effect of inflammation on recording quality and stimulation efficiency, as well as long-term device stability. In addition, I will investigate how changes in the foreign body response affect the remodeling of tissue surrounding the implant. I will take the approach of loading SNP coated MEAs with DNA encoding CRISPR gene therapy vectors targeting inflammatory pathways in microglia. The CRISPR vectors will be electrochemically delivered to cells directly interfacing with the implanted devices. The development of this technology has great potential to enhance the therapeutic value of implanted devices by increasing their performance and longevity by reducing inflammation and gliosis and to increase our fundamental understanding of how the brain responds to implanted devices. Once established, this technology will be a versatile platform for highly targeted gene delivery, having both spatiotemporal and cell-type specificity.

摘要